AIM IMMUNOTECH INC. Inventory, LIFO Reserve, Effect on Income, Net
AIM IMMUNOTECH INC. (AIM) reported Inventory, LIFO Reserve, Effect on Income, Net of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-19.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InventoryLIFOReserveEffectOnIncomeNet · last filed 2016-03-29
- AIM IMMUNOTECH INC. inventory, lifo reserve, effect on income, net for the quarter ending 2012-12-31 was $245.00K.
- AIM IMMUNOTECH INC. inventory, lifo reserve, effect on income, net for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- AIM IMMUNOTECH INC. inventory, lifo reserve, effect on income, net for fiscal 2013 was $453.00K, a 55.72% decline from fiscal 2012.
- AIM IMMUNOTECH INC. inventory, lifo reserve, effect on income, net for fiscal 2012 was $1.02M.
- AIM IMMUNOTECH INC. inventory, lifo reserve, effect on income, net for fiscal 2011 was $0.00.
| Period end | Inventory, LIFO Reserve, Effect on Income, Net 3 month | Inventory, LIFO Reserve, Effect on Income, Net 9 month | Inventory, LIFO Reserve, Effect on Income, Net 12 month |
|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-19 | ||
| 2013-12-31 | $453.00K 10-K · filed 2016-03-29 | ||
| 2012-12-31 | $245.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $1.02M 10-K · filed 2015-03-19 | |
| 2012-09-30 | $778.00K 10-Q · filed 2012-11-02 | ||
| 2011-12-31 | $0.00 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |